ClassID:

94773

C07D277/593 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom Z being doubly bound oxygen or doubly bound nitrogen, which nitrogen is part of a possibly substituted oximino radical

Recent Application in this class:
#1
20250197869
2025-06-19

Ribosome-Mediated Incorporation of Peptides and Peptidomimetics

#2
20250135024
2025-05-01

Drug-Conjugates, Conjugation Methods, And Uses Thereof

#3
20230046194
2023-02-16

Ribosome-mediated incorporation of peptides and peptidomimetics

#4
20220402884
2022-12-22

(S)-N-HYDROXY-2-(2-(4-METHOXYPHENYL)BUTANAMIDO)THIAZOLE-5-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

#5
20220259144
2022-08-18

Compounds as NLRP3 inflammasome inhibitors and compositions and uses thereof

#6
20210347747
2021-11-11

(S)-n-hydroxy-2-(2-(4-methoxyphenyl)butanamido)thiazole-5-carboxamide and pharmaceutically acceptable salts thereof

#7
20210187119
2021-06-24

Drug-conjugates, conjugation methods, and uses thereof

#8
20200370057
2020-11-26

Ribosome-mediated incorporation of peptides and peptidomimetics

#9
20190233439
2019-08-01

Histone deacetylase inhibitors

#10
20190040023
2019-02-07

Modulators of indoleamine 2,3-dioxygenase

#11
20180370987
2018-12-27

Histone deacetylase inhibitors

#12
20180243438
2018-08-30

Drug-conjugates, conjugation methods, and uses thereof

#13
20180085471
2018-03-29

DRUG-CONJUGATES, CONJUGATION METHODS, AND USES THEREOF

#14
20180002709
2018-01-04

Ribosome-mediated incorporation of peptides and peptidomimetics

#15
20170050984
2017-02-23

Histone deacetylase inhibitors

#16
20160067350
2016-03-10

Drug-conjugates, conjugation methods, and uses thereof

#17
20150336916
2015-11-26

Epoxyeicosatrienoic acid analogs and methods of making and using the same

#18
20150148373
2015-05-28

Heterocyclic guanidine FF-atpase inhibitors and therapeutic uses thereof

#19
20150141646
2015-05-21

Drug-conjugates, conjugation methods, and uses thereof

#20
20150105539
2015-04-16

Drug-conjugates, conjugation methods, and uses thereof

#21
20150038523
2015-02-05

Integrin antagonist conjugates for targeted delivery to cells expressing alpha-V-beta-3

#22
20140275554
2014-09-18

Crystalline form of a substituted thiazolylacetic acid triethylamine salt

#23
20140113884
2014-04-24

Epoxyeicosatrienoic acid analogs and methods of making and using the same

#24
20140045850
2014-02-13

INHIBITORS OF HISTONE DEACETYLASE

#25
20130190368
2013-07-25

NOVEL POLYMORPHS OF FEBUXOSTAT

#26
20130131085
2013-05-23

CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF

#27
20130090479
2013-04-11

Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

#28
20120309762
2012-12-06

CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF

#29
20120083490
2012-04-05

CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF

#30
20110021771
2011-01-27

Inhibitors of histone deacetylase

#31
20090306155
2009-12-10

Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

#32
20080161246
2008-07-03

Cytochrome P450 Oxidase Inhibitors and Uses Thereof

#33
20070298065
2007-12-27

Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases